Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment

Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment

US Patent 10646521 · Granted May 12, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for predicting the risk of developing pulmonary colonization/infection b2025
Chimeric antigen receptor effector cell switches with humanized targeting moieti2025
Bacterial and cell compositions for the treatment of colorectal cancer and metho2025
Immune checkpoint inhibitor combinations2025
Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 an2024
Immunogenic sequences from a phage tail length tape measure protein, bacteria ex2024
Methods for predicting the risk of developing pulmonary colonization/infection b2024
Microbiota composition, as a marker of responsiveness to anti-PD1/PD-L1/PD-L2 an2023
Microbiota composition, as a marker of responsiveness to chemotherapy, and use o2022
Microbiota composition, as a marker of responsiveness to chemotherapy, and use o2022
Microbiota composition, as a marker of responsiveness to chemotherapy, and use o2022
Microbiota composition, as a marker of responsiveness to chemotherapy, and use o2022